about
Vor Biopharma Inc is a clinical stage cell therapy company. It combines a novel patient engineering approach with targeted therapies to provide a solution for patients suffering from hematological malignancies. The company's products include VCAR33, ...
Read More
13.47
-0.29
(-2.11%)
272.0K
XNAS Volume
XNAS 17 Mar, 2026 1:05 PM (EDT)
Board Meeting
The next board meeting for Vor Biopharma Inc is on 20 Mar 2026 for the purpose of Vor Biopharma Inc Fourth Quarter Earnings Results for 2025
See details
Not Eligible
Expensive Valuation
Technically Neutral
Vor Biopharma Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..